Achaogen Stock

Achaogen Financial Leverage

Delisted

The Financial Leverage (Equity Multiplier) of Achaogen (AKAOQ) as of Aug 13, 2026 is -13.09. In the previous year, Financial Leverage (Equity Multiplier) was 1.62 — a change of -910.04% (lower).

Financial Leverage

-13.09

YoY

-910.04%

Last updated:

Financial Leverage (Equity Multiplier) of Achaogen is 2026 -13.09 . Financial Leverage (Equity Multiplier) of Achaogen was 2025 1.62 . It decreases by -910.04% lower compared to the previous year.
Access this data via the Eulerpool API

Achaogen Stock analysis

What does Achaogen do? Achaogen Inc is an innovative biotechnology company specializing in the development of antibiotics for the treatment of life-threatening infectious diseases. The company's business model is based on research and development of new antibiotics, aiming to improve medical care for patients with infections. Achaogen was founded in 2002 by a team of researchers and professionals in the biotechnology industry and has developed several products for the treatment of diseases such as pneumonia, urinary tract infections, and bloodstream infections. The company's main divisions include Plazomicin, Zemdri, and C-Scape, which are antibiotics targeting different types of infections. Achaogen is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Achaogen stock

Financial Leverage (Equity Multiplier) of Achaogen is -13.09 in 2026.

Financial Leverage (Equity Multiplier) of Achaogen changed from 1.62 to -13.09, representing a -910.04% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Achaogen since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Achaogen with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Leverage — Achaogen

All Key Metrics — Achaogen